Interventional Cardiology - European Medical Journal

This site is intended for healthcare professionals

Continue

Interventional Cardiology

Filter
6 Aug 2018

A Bioengineered Left Heart Ventricle Model

A three-dimensional (3D) model of a human left heart ventricle has been successfully bioengineered by researchers at Harvard University, Cambridge…
10 Jul 2018

European Medical Journal Presents: EMJ Interventional Cardiology 6.1

The eagerly awaited EMJ Interventional Cardiology 6.1, offering a comprehensive and independent review of EuroPCR 2018, is now available for all to enjoy.
10 Apr 2018

Mathematical Model Could Improve Treatment for Abdominal Aortic Aneurysms

Treatment of abdominal aortic aneurysms (AAA) could be enhanced following the development of a mathematical model that can help prevent movement of the…
13 Nov 2017

Significant Mortality Benefits of Mechanical Valves

MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…
7 Aug 2017

3D-Printed Models: The Future of Heart Valve Replacement

OUTCOMES of heart valve replacements could be revolutionised through the use of three-dimensional (3D)-printed models, which could boost the success of…
4 Jul 2017

Introducing EMJ Interventional Cardiology 5.1

United Kingdom, July 04, 2017: Welcome to the latest edition of EMJ Interventional Cardiology. This instalment is bursting with the latest news from…
13 Jun 2017

Acarix Receives First Commercial Order for CADScor®System for Early Detection of Coronary Artery Disease from Danish Hospital

Malmö, Sweden, 13 June, 2017 – Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order…
5 Apr 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
We’ve noticed you’re accessing
from North/South America.